Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 24 (Search time: 0.006 seconds).
previous
1
2
3
next
Item hits:
Preview
Issue Date
Title
Author(s)
2003
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase
Branford, S.
;
Rudzki, Z.
;
Harper, A.
;
Grigg, A.
;
Taylor, K.
;
Durrant, S.
;
Arthur, C.
;
Browett, P.
;
Schwarer, A.
;
Ma, D.
;
Seymour, J.
;
Bradstock, K.
;
Joske, D.
;
Lynch, K.
;
Gathmann, I.
;
Hughes, T.
2002
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance
Branford, S.
;
Rudzki, Z.
;
Walsh, S.
;
Grigg, A.
;
Arthur, C.
;
Taylor, K.
;
Herrmann, R.
;
Lynch, K.
;
Hughes, T.
2007
Monitoring disease response
Hughes, T.
;
Branford, S.
;
Melo, J.
;
Goldman, J.
2007
Reliability of PCR for BCR-ABL transcripts
Hughes, T.
;
Branford, S.
;
Goldman, J.
2009
A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph plus CML or relapsed/refractory Ph plus ALL
Tojo, A.
;
Usuki, K.
;
Urabe, A.
;
Maeda, Y.
;
Kobayashi, Y.
;
Jinnai, I.
;
Ohyashiki, K.
;
Nishimura, M.
;
Kawaguchi, T.
;
Tanaka, H.
;
Miyamura, K.
;
Miyazaki, Y.
;
Hughes, T.
;
Branford, S.
;
Okamoto, S.
;
Ishikawa, J.
;
Okada, M.
;
Usui, N.
;
Tanii, H.
;
Amagasaki, T.
;
et al.
2009
Genomic translocation breakpoint sequences are conserved in BCR-ABL1 cell lines despite the presence of amplification
Ross, D.
;
Schafranek, L.
;
Hughes, T.
;
Nicola, M.
;
Branford, S.
;
Score, J.
2006
Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL
Ross, D.
;
Branford, S.
;
Moore, S.
;
Hughes, T.
2000
A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemia
Branford, S.
;
Rudzi, Z.
;
Hughes, T.
2009
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia
Hochhaus, A.
;
O'Brien, S.
;
Guilhot, F.
;
Druker, B.
;
Branford, S.
;
Foroni, L.
;
Goldman, J.
;
Muller, M.
;
Radich, J.
;
Rudoltz, M.
;
Mone, M.
;
Gathmann, I.
;
Hughes, T.
;
Larson, R.
2009
Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value
Hochhaus, A.
;
Muller, M.
;
Radich, J.
;
Branford, S.
;
Kantarjian, H.
;
Hanfstein, B.
;
Rousselot, P.
;
Kim, D.
;
Lipton, J.
;
Bleickhardt, E.
;
Lambert, A.
;
Hughes, T.
Discover
Author
7
Rudzki, Z.
6
Hochhaus, A.
6
Radich, J.
5
Goldman, J.
5
Grigg, A.
4
Arthur, C.
4
Lynch, K.
4
Muller, M.
4
Seymour, J.
3
Gathmann, I.
.
next >
Subject
5
Adult
5
Aged
5
Drug Resistance, Neoplasm
5
Female
5
Reverse Transcriptase Polymerase ...
5
Treatment Outcome
4
imatinib
4
Mutation
3
Antineoplastic Agents
3
chronic myeloid leukemia
.
< previous
next >
Date issued
8
2009
1
2008
3
2007
3
2006
1
2005
5
2003
2
2002
1
2000